You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

hyd-sulfate AZD6244

Showing 1 - 25 of 860
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Uveal Melanoma Trial in New York, Houston (Selumetinib)

Active, not recruiting
  • Uveal Melanoma
  • New York, New York
  • +2 more
Jun 28, 2022

Neurofibromatosis 1, Neurofibromatosis Type 1, NF1 Trial run by the National Cancer Institute (NCI) (AZD6244)

Active, not recruiting
  • Neurofibromatosis 1
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV Trial in Worldwide (Selumetinib 75 mg, Docetaxel 75

Completed
Has Results
  • Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
  • Selumetinib 75 mg
  • +3 more
  • Santa Monica, California
  • +50 more
Nov 22, 2022

Neurofibromatosis 1 (NF1), Plexiform Neurofibromas (PN) Trial run by the NCI (Selumetinib)

Active, not recruiting
  • Neurofibromatosis 1 (NF1)
  • Plexiform Neurofibromas (PN)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 31, 2023

Recurrent Endometrial Carcinoma, Recurrent Ovarian Carcinoma Trial (Biopsy, Biospecimen Collection, Bone Marrow Aspiration and

Not yet recruiting
  • Recurrent Endometrial Carcinoma
  • Recurrent Ovarian Carcinoma
  • Biopsy
  • +5 more
  • (no location specified)
Sep 29, 2022

Malignant Peripheral Nerve Sheath Tumors, Neurofibromatosis 1 Trial in United States (Selumetinib, Sirolimus)

Active, not recruiting
  • Malignant Peripheral Nerve Sheath Tumors
  • Neurofibromatosis 1
  • Washington, District of Columbia
  • +4 more
Apr 1, 2022

Breast Cancer, Breast Tumors, Colon Cancer Trial in United States (AZD6244, Dacarbazine, Erlotinib)

Active, not recruiting
  • Breast Cancer
  • +7 more
  • Detroit, Michigan
  • +3 more
Dec 22, 2022

Advanced Malignant Solid Tumor, Locally Advanced Malignant Solid Tumor Trial (drug, procedure, biological)

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • Locally Advanced Malignant Solid Neoplasm
  • (no location specified)
Dec 2, 2022

Non-Metastatic Adenocarcinoma of the Rectum Trial run by the NCI (Radiation Therapy, Capecitabine, AZD6244)

Terminated
Has Results
  • Non-Metastatic Adenocarcinoma of the Rectum
  • Radiation Therapy
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 1, 2021

KRAS NP_004976.2:p.G12R, Stage III Pancreatic Cancer AJCC v6 and v7, Stage IV Pancreatic Cancer AJCC v6 and v7 Trial in United

Completed
Has Results
  • KRAS NP_004976.2:p.G12R
  • +2 more
  • Laboratory Biomarker Analysis
  • Selumetinib Sulfate
  • Los Angeles, California
  • +8 more
Jan 20, 2021

Lung Cancer, Melanoma, Head and Neck Carcinoma Trial in United States (Selumetinib, MEDI4736, Tremelimumab)

Completed
  • Lung Cancer
  • +7 more
  • Chicago, Illinois
  • +5 more
Nov 15, 2019

Tumors, Nerve Tissue, Neurofibromatosis 1, Heredodegenerative Disorders, Nervous System Trial (Selumetinib (AZD6244 hyd sulfate)

Withdrawn
  • Neoplasms, Nerve Tissue
  • +3 more
  • Selumetinib (AZD6244 hyd sulfate) 50mg/dose
  • Selumetinib (AZD6244 hyd sulfate) 25mg/m2
  • (no location specified)
Apr 3, 2019

Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV Trial in Worldwide (Selumetinib, Docetaxel, Placebo)

Active, not recruiting
Has Results
  • Locally Advanced or Metastatic Non Small Cell Lung Cancer Stage IIIb - IV
  • Aurora, Colorado
  • +196 more
Dec 22, 2022

Recurrent Low Grade Astrocytoma, Recurrent WHO Grade 2 Glioma, Refractory Low Grade Astrocytoma Trial in Canada, United States

Recruiting
  • Recurrent Low Grade Astrocytoma
  • +4 more
  • Quality-of-Life Assessment
  • +3 more
  • Birmingham, Alabama
  • +64 more
Aug 20, 2022

Borderline Ovarian Serous Tumor, Low Grade Ovarian Serous Adenocarcinoma, Micropapillary Serous Carcinoma Trial in United States

Completed
Has Results
  • Borderline Ovarian Serous Tumor
  • +5 more
  • Laboratory Biomarker Analysis
  • +3 more
  • Los Angeles, California
  • +48 more
Dec 2, 2020

Low Grade Glioma, Neurofibromatosis Type 1, Visual Pathway Glioma Trial in Canada, Puerto Rico, United States (Carboplatin,

Recruiting
  • Low Grade Glioma
  • +2 more
  • Birmingham, Alabama
  • +120 more
Jan 27, 2023

Advanced Malignant Solid Tumor, Ann Arbor Stage III Non-Hodgkin Lymphoma, Ann Arbor Stage IV Non-Hodgkin Lymphoma Trial in

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +44 more
  • Biopsy
  • +23 more
  • Birmingham, Alabama
  • +166 more
Feb 2, 2023

Tumor, Cancer Trial in Netherlands, United Kingdom, United States (AZD6244)

Active, not recruiting
  • Tumor
  • Cancer
  • Aurora, Colorado
  • +3 more
Dec 22, 2022

Colonoscopy Trial (DWJ1609, DWC202304)

Not yet recruiting
  • Colonoscopy
  • (no location specified)
Sep 24, 2023

Bowel Preparation Trial in Nanjing (OSS, OSS+Linzess, PEG-Interferon Alfa)

Recruiting
  • Bowel Preparation
  • Nanjing, Jiangsu, China
    A single-center, single-blind, randomized controlled clinical st
Oct 20, 2023

Healthy, Irritation/Irritant, Reactions Adverse Trial (NS Solution, Normal Saline, SLS)

Completed
  • Healthy
  • +2 more
  • NS Solution
  • +2 more
  • (no location specified)
Nov 1, 2023

Pharmacokinetics Trial in Hong Kong (Atropine sulfate eye drops)

Recruiting
  • Pharmacokinetics
  • Atropine sulfate eye drops
  • Hong Kong, China
    HKU Eye Centre
May 2, 2023

ESPB, Mg Sulfate,Post Mastectomy Trial (Magnesium sulfate in erector spinae plane block)

Not yet recruiting
  • ESPB, Mg Sulfate,Post Mastectomy
  • Magnesium sulfate in erector spinae plane block
  • (no location specified)
Jul 27, 2023

Colonoscopy, Bowel Preparation Trial in Kingston (oral sodium sulfate)

Not yet recruiting
  • Colonoscopy
  • Bowel Preparation
  • oral sodium sulfate
  • Kingston, Ontario, Canada
  • +1 more
Sep 18, 2023

LPIN1 Mutations Treated With Low Dose Hydroxychloroquine Sulfate

Not yet recruiting
  • Lipin-1 Deficiency
    • (no location specified)
    Sep 29, 2022